WebMonitor serum electrolytes, calcium, phosphate and magnesium. Monitor renal function in patients at risk, such as those with pre-existing renal impairment, those of advanced age, … WebBisphosphonates are used to treat osteoporosis, osteitis deformans (Paget's disease of the bone), bone metastasis (with or without hypercalcemia), multiple myeloma, and other conditions involving fragile, breakable bone. In osteoporosis and Paget's, the most popular first-line bisphosphonate drugs are alendronate and risedronate.
Bisphosphonate Article - StatPearls
WebJan 1, 2024 · BTMs are a simple, low-risk, and convenient way to monitor effectiveness and adherence to oral bisphosphonate therapy in addition to DXA. Bisphosophonates … WebMar 16, 2024 · Bisphosphonates work by slowing down the cells which break down bone (osteoclasts). Therefore they slow down bone loss, allowing the bone cells (osteoblasts) that help to build the bone to work more effectively. They can help to strengthen bone and help to prevent it getting any weaker. edsby create account
Osteoporosis - prevention of fragility fractures: Scenario: …
WebIf bone-sparing treatment is recommended, prescribe a bisphosphonate (alendronate 10 mg once daily or 70 mg once weekly, or risedronate 5 mg once daily or 35 mg once … WebAug 9, 2024 · Guidance. Evidence-based recommendations on the bisphosphonates alendronic acid, ibandronic acid, risedronate sodium and zoledronic acid for treating osteoporosis. NICE has produced a patient decision aid on bisphosphonates for treating osteoporosis to support discussions. WebBisphosphonates are first-line agents used for the treatment of osteoporosis in postmenopausal women and men. Although their efficacy in the reduction of vertebral, non-vertebral and hip fracture risk has been established, some concerns have arisen associated with their long-term use. These include osteonecrosis of the jaw and atypical ... edsby chat login